Fundraising FoxCrowdcube — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
TC Biopharmtcbiopharm.comNov 2022
Developing a scalable off-the-shelf allogeneic gamma delta T cell therapy platform.
BiotechHolytown, Motherwell
Martin Thorp(Executive Officer, Director)Edward Niemczyk(Director)Mark Bonyhadi(Director)Michael Leek(Director)Arlene Morris(Director)James Culverwell(Director)
Co-investorsInvesting Women AngelsNCL Technology Ventures Ltd.Scottish Enterprise
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.